midpage
Projects
Sign in to see your projects.
16 F. Supp. 3d 1341
N.D. Ala.
2014
Read the full case

Background

  • Plaintiff, a 26-year-old woman, allegedly suffered injuries from Mirena, a uterus-placed device releasing levonorgestrel.
  • Plaintiff asserts Mirena causes pseudo-tumor cerebri/idiopathic intracranial hypertension (PTC/IIH) with potential vision loss.
  • Defendant Bayer moves to dismiss under Rule 12(b)(6) for failure to state a claim; court has diversity jurisdiction (Alabama plaintiff, New Jersey defendant, >$75,000).
  • Plaintiff asserts nine state-law claims, including implied, express warranties, negligence, AEMLD strict liability, and fraud-based claims.
  • Court applies Twombly/Iqbal plausibility standard and analyzes global deficiency theory versus individual claims.
  • Court grants in part: implied warranty claim is dismissed; all other claims survive the motion.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Implied warranty viability against Mirena Spain/Allen allow implied warranty separate from torts for dangerous products. Implied warranty does not cover health hazards if product fulfills primary purpose. Implied warranty claim dismissed
Negligent design claim sufficiency Complaint contains design-defect facts and foreseeability; plausible duty/breach. Counts rely on conclusory statements; lacks factual support. Plaintiff survives dismissal; design claim plausible
AEMLD design-defect claim viability Mirena is defective/unreasonably dangerous when used as intended. Design defect arguments based on non-Alabama doctrines; argues Mirena not defective by design. AEMLD claim survives
Breach of express warranty viability Express warranties alleged regarding Mirena being safe and effective; reliance shown. Plaintiff must show specific affirmation, description, or basis of bargain; arguments insufficient. Express warranty claim dismissed
Fraud-based and failure-to-warn claims under Rule 9(b) Adequate particularity based on labeling warnings and duty to warn. Raises pleading requirements but not fatal at this stage. Fraud-based claims denied dismissal; failure-to-warn claim survives

Key Cases Cited

  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (U.S. 2007) (two-pronged plausibility standard)
  • Ashcroft v. Iqbal, 556 U.S. 662 (U.S. 2009) (plausibility pleading standard)
  • Shell v. Union Oil Co., 489 So.2d 569 (Ala. 1986) (implied warranty not a health-hazard warranty under UCC)
  • Spain v. Brown & Williamson Tobacco Corp., 872 So.2d 101 (Ala. 2003) (implied warranty analysis includes fact-intensive context)
  • Allen v. Delchamps, Inc., 624 So.2d 1065 (Ala. 1993) (food products; implied warranty and AMELD can interplay)
  • Yamaha Motor Co., Ltd. v. Thornton, 579 So.2d 619 (Ala. 1991) (AEMLD: defect unreasonably dangerous if product unsafe as used)
  • Casrell v. Altec Indus., Inc., 335 So.2d 128 (Ala. 1976) (defect focus on safety of product for intended use)
  • Rudd v. Gen. Motors Corp., 127 F.Supp.2d 1330 (M.D. Ala. 2001) (design/danger analysis for AEMLD context)
Read the full case

Case Details

Case Name: Houston v. Bayer Healthcare Pharmaceuticals, Inc.
Court Name: District Court, N.D. Alabama
Date Published: Mar 28, 2014
Citations: 16 F. Supp. 3d 1341; 2014 WL 1330906; 2014 U.S. Dist. LEXIS 43641; 83 U.C.C. Rep. Serv. 2d (West) 323; Civil Action No. 2:14-CV-00035-WMA
Docket Number: Civil Action No. 2:14-CV-00035-WMA
Court Abbreviation: N.D. Ala.
Log In